FDA Inspection 1032424 — QPharma, Inc.
The FDA completed an inspection of QPharma, Inc. on September 26, 2017 in Cedar Knolls, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 26, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cedar Knolls, NJ (United States)